Literature DB >> 15857189

Risk assessment for inherited susceptibility to cancer: a review of the psychosocial and ethical dimensions.

Robert C Lee1, Leanne Kmet, Linda S Cook, Diane Lorenzetti, Glenys Godlovitch, Edna Einsiedel.   

Abstract

The objective of this study was to conduct a broad-based systematic review of social, ethical, and legal considerations associated with genetic cancer risk assessment technologies (CaRATs). This paper focuses on psychosocial and ethical issues. Search results were limited to papers published in English, French, or German from January, 1990, to May, 2003. A quality assessment tool was developed and applied to retrieved papers. Application of the quality assessment tool resulted in 77 of 247 qualitative and quantitative primary research papers being reviewed and synthesized. A broad range of issues were addressed and grouped into content areas. Despite a large literature addressing psychosocial and ethical issues associated with CaRATs, many existing studies are not adequate to inform decision-makers and stakeholders. Careful policy analysis, as in some of the economic analyses reviewed here, is important to bridge this gap.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Genetics and Reproduction

Mesh:

Year:  2005        PMID: 15857189     DOI: 10.1089/gte.2005.9.66

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  2 in total

1.  Attitudes of patients with cancer about personalized medicine and somatic genetic testing.

Authors:  Stacy W Gray; Katherine Hicks-Courant; Christopher S Lathan; Levi Garraway; Elyse R Park; Jane C Weeks
Journal:  J Oncol Pract       Date:  2012-08-07       Impact factor: 3.840

2.  Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions.

Authors:  Karine Gravel; France Légaré; Ian D Graham
Journal:  Implement Sci       Date:  2006-08-09       Impact factor: 7.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.